Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04087811 · ClinicalTrials.gov registry record
Postmarket Registry for Evaluation of the Superion® Spacer
A clinical trial, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- 1,674
- Enrollment target
NCT04087811 is a clinical trial that has completed, run by Boston Scientific Corporation. The registered enrollment target is 1,674 participants.
The verdict
NCT04087811 has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- 1,674 participants
- Enrollment target
Study Summary
To gather evidence documenting the performance and clinical outcomes associated with treatment of moderate degenerative lumbar spinal stenosis using the Superion® Indirect Decompression System (IDS).
Interventions
- DEVICE Superion® Indirect Decompression System (IDS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,674 participants |
| Start Date | 2016-11-28 |
| Est. Completion | 2021-03-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04087811
The ClinicalTrials.gov registry entry for NCT04087811 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,674 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Superion® Indirect Decompression System (IDS) is the first listed.
NCT04087811 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04087811 about?
NCT04087811 is a clinical study titled "Postmarket Registry for Evaluation of the Superion® Spacer". To gather evidence documenting the performance and clinical outcomes associated with treatment of moderate degenerative lumbar spinal stenosis using the Superion® Indirect Decompression System (IDS).
What is the current status of trial NCT04087811?
This trial is currently completed. The enrollment target is 1,674 participants. The study started on 2016-11-28. Estimated completion is 2021-03-01.
What interventions are being tested in trial NCT04087811?
The interventions under investigation include: Superion® Indirect Decompression System (IDS) (DEVICE).
Who is sponsoring clinical trial NCT04087811?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.